| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |